conv.

← The whole story
Health
FDA examines testosterone therapy for menopausal women amid rising off-label use

FDA announces public workshop on testosterone therapy for menopausal women

1 Sep 17 · 6d ago · 2 articles · 1 source · development 1 of 2

The FDA announced it will hold a public meeting to review scientific evidence on testosterone use in menopausal women, including its benefits, risks, dosing, and role in female health. The meeting is intended to help guide future research and drug development as growing numbers of women turn to testosterone to manage menopause symptoms.

FDA announces public workshop on testosterone therapy for menopausal women
abcnews.com

“The lack of a female-specific product creates practical challenges for clinicians, said Dr. Diana Tordoff, an instructor in obstetrics and gynecology at Stanford, noting that an approved product could provide standardized dosing, labeling and safety-monitoring guidance.”

Dr. Diana Tordoff, Instructor in obstetrics and gynecology, Stanford · rss ↗

Dr. Stephanie Faubion Director, Mayo Clinic Center for Women's HealthDr. Diana Tordoff Instructor in obstetrics and gynecology, StanfordDr. Karen Adams Director, Stanford Medicine's Program in Menopause and Healthy AgingFDA US health regulator

The whole story articlesposts the bright band is this development · numbered dots are the others · click one to jump

Peak 2 pieces in two hours at Sep 17, 5 AM; 7 pieces over 7 days (6 articles · 1 post) Sep 17, 5 AM — 2 pieces · 2 articles — Google News 1, Newswires 1Sep 17, 7 AM — 1 piece · 1 article — Newswires 1Sep 17, 9 AM — quietSep 17, 11 AM — quietSep 17, 1 PM — quietSep 17, 3 PM — quietSep 17, 5 PM — quietSep 17, 7 PM — quietSep 17, 9 PM — quietSep 17, 11 PM — quietSep 18, 1 AM — quietSep 18, 3 AM — quietSep 18, 5 AM — quietSep 18, 7 AM — quietSep 18, 9 AM — quietSep 18, 11 AM — 1 piece · 1 article — Newswires 1Sep 18, 1 PM — quietSep 18, 3 PM — quietSep 18, 5 PM — 2 pieces · 1 article · 1 post — Mastodon 1, Newswires 1Sep 18, 7 PM — quietSep 18, 9 PM — quietSep 18, 11 PM — quietSep 19, 1 AM — quietSep 19, 3 AM — quietSep 19, 5 AM — quietSep 19, 7 AM — 1 piece · 1 article — Google News 1Sep 19, 9 AM — quietSep 19, 11 AM — quietSep 19, 1 PM — quietSep 19, 3 PM — quietSep 19, 5 PM — quietSep 19, 7 PM — quietSep 19, 9 PM — quietSep 19, 11 PM — quietSep 20, 1 AM — quietSep 20, 3 AM — quietSep 20, 5 AM — quietSep 20, 7 AM — quietSep 20, 9 AM — quietSep 20, 11 AM — quietSep 20, 1 PM — quietSep 20, 3 PM — quietSep 20, 5 PM — quietSep 20, 7 PM — quietSep 20, 9 PM — quietSep 20, 11 PM — quietSep 21, 1 AM — quietSep 21, 3 AM — quietSep 21, 5 AM — quietSep 21, 7 AM — quietSep 21, 9 AM — quietSep 21, 11 AM — quietSep 21, 1 PM — quietSep 21, 3 PM — quietSep 21, 5 PM — quietSep 21, 7 PM — quietSep 21, 9 PM — quietSep 21, 11 PM — quietSep 22, 1 AM — quietSep 22, 3 AM — quietSep 22, 5 AM — quietSep 22, 7 AM — quietSep 22, 9 AM — quietSep 22, 11 AM — quietSep 22, 1 PM — quietSep 22, 3 PM — quietSep 22, 5 PM — quietSep 22, 7 PM — quietSep 22, 9 PM — quietSep 22, 11 PM — quietYesterday, 1 AM — quietYesterday, 3 AM — quietYesterday, 5 AM — quietYesterday, 7 AM — quietYesterday, 9 AM — quietYesterday, 11 AM — quietYesterday, 1 PM — quietYesterday, 3 PM — quietYesterday, 5 PM — quietYesterday, 7 PM — quietYesterday, 9 PM — quietYesterday, 11 PM — quietToday, 1 AM — quiet 12
1FDA announces public workshop on…2FDA public workshop on testosterone…
Sep 18Sep 19Sep 20Sep 21Sep 22yesterdaynow · 3:51 AM ET

What was reported 1 claim about this development

  1. 2 outlets US regulators to examine testosterone therapy as use by menopausal women rises

    first by Daily Maverick, 6d ago · also Medscape

All 2 developments of FDA examines testosterone therapy for menopausal women amid… →

NewswiresMastodonGoogle News